A Retrospective Analysis of 10 Years of Liver Surveillance Undertaken in Uveal Melanoma Patients Treated at the Supraregional “Liverpool Ocular Oncology Centre”, UK

Purpose: To determine liver screening frequency and modality in UM patients following primary treatment, and the characteristics of detected metastases. Methods: A 10-year retrospective study of 615 UM patients undergoing liver surveillance in Liverpool. Information was collected from liver scan rep...

Full description

Bibliographic Details
Main Authors: Alda Cunha Rola, Helen Kalirai, Azzam F. G. Taktak, Antonio Eleuteri, Yamini Krishna, Rumana Hussain, Heinrich Heimann, Sarah E. Coupland
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/9/2187
_version_ 1797505395606945792
author Alda Cunha Rola
Helen Kalirai
Azzam F. G. Taktak
Antonio Eleuteri
Yamini Krishna
Rumana Hussain
Heinrich Heimann
Sarah E. Coupland
author_facet Alda Cunha Rola
Helen Kalirai
Azzam F. G. Taktak
Antonio Eleuteri
Yamini Krishna
Rumana Hussain
Heinrich Heimann
Sarah E. Coupland
author_sort Alda Cunha Rola
collection DOAJ
description Purpose: To determine liver screening frequency and modality in UM patients following primary treatment, and the characteristics of detected metastases. Methods: A 10-year retrospective study of 615 UM patients undergoing liver surveillance in Liverpool. Information was collected from liver scan reports of these patients. Results: Of 615 UM patients analyzed, there were 337 men (55%) and 278 women (45%). Median age at primary treatment was 61 years (range, 22–94). At study end, median follow-up was 5.1 years, with 375 patients (61%) alive and 240 deceased (39%). Of the deceased patients, 187 (78%) died due to metastatic UM; 24 (10%) deaths were due to other causes; and 29 (12%) patients died of unknown conditions. In total, 3854 liver scans were performed in the 615 UM patients, with a median of 6.2 scans per patient (range, 1–40). Liver MRI was most frequently performed (62.8%). In total, 229 (37%) UM patients developed metastases during the study period: 150 were detected via liver surveillance and 79 were observed post-mortem. Conclusions: Metastatic UM onset is related to the size and genetic profiles of the primary UM, and can be predicted using the model LUMPO3. Regular liver surveillance allowed for timely detection of metastases, and through metastasectomy can lead to prolongation of life in some patients.
first_indexed 2024-03-10T04:18:02Z
format Article
id doaj.art-71dbf3f9afd64a17a8e4e2970a8f39b6
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T04:18:02Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-71dbf3f9afd64a17a8e4e2970a8f39b62023-11-23T07:56:05ZengMDPI AGCancers2072-66942022-04-01149218710.3390/cancers14092187A Retrospective Analysis of 10 Years of Liver Surveillance Undertaken in Uveal Melanoma Patients Treated at the Supraregional “Liverpool Ocular Oncology Centre”, UKAlda Cunha Rola0Helen Kalirai1Azzam F. G. Taktak2Antonio Eleuteri3Yamini Krishna4Rumana Hussain5Heinrich Heimann6Sarah E. Coupland7Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of System Molecular and Integrative Biology, University of Liverpool, 6 West Derby Street, William Henry Duncan Building, Liverpool L7 8TX, UKLiverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of System Molecular and Integrative Biology, University of Liverpool, 6 West Derby Street, William Henry Duncan Building, Liverpool L7 8TX, UKLiverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of System Molecular and Integrative Biology, University of Liverpool, 6 West Derby Street, William Henry Duncan Building, Liverpool L7 8TX, UKLiverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of System Molecular and Integrative Biology, University of Liverpool, 6 West Derby Street, William Henry Duncan Building, Liverpool L7 8TX, UKLiverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of System Molecular and Integrative Biology, University of Liverpool, 6 West Derby Street, William Henry Duncan Building, Liverpool L7 8TX, UKLiverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of System Molecular and Integrative Biology, University of Liverpool, 6 West Derby Street, William Henry Duncan Building, Liverpool L7 8TX, UKLiverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of System Molecular and Integrative Biology, University of Liverpool, 6 West Derby Street, William Henry Duncan Building, Liverpool L7 8TX, UKLiverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of System Molecular and Integrative Biology, University of Liverpool, 6 West Derby Street, William Henry Duncan Building, Liverpool L7 8TX, UKPurpose: To determine liver screening frequency and modality in UM patients following primary treatment, and the characteristics of detected metastases. Methods: A 10-year retrospective study of 615 UM patients undergoing liver surveillance in Liverpool. Information was collected from liver scan reports of these patients. Results: Of 615 UM patients analyzed, there were 337 men (55%) and 278 women (45%). Median age at primary treatment was 61 years (range, 22–94). At study end, median follow-up was 5.1 years, with 375 patients (61%) alive and 240 deceased (39%). Of the deceased patients, 187 (78%) died due to metastatic UM; 24 (10%) deaths were due to other causes; and 29 (12%) patients died of unknown conditions. In total, 3854 liver scans were performed in the 615 UM patients, with a median of 6.2 scans per patient (range, 1–40). Liver MRI was most frequently performed (62.8%). In total, 229 (37%) UM patients developed metastases during the study period: 150 were detected via liver surveillance and 79 were observed post-mortem. Conclusions: Metastatic UM onset is related to the size and genetic profiles of the primary UM, and can be predicted using the model LUMPO3. Regular liver surveillance allowed for timely detection of metastases, and through metastasectomy can lead to prolongation of life in some patients.https://www.mdpi.com/2072-6694/14/9/2187liver surveillancefrequencymodalitydetection of metastasesLUMPO3 modelnew output of LUMPO3
spellingShingle Alda Cunha Rola
Helen Kalirai
Azzam F. G. Taktak
Antonio Eleuteri
Yamini Krishna
Rumana Hussain
Heinrich Heimann
Sarah E. Coupland
A Retrospective Analysis of 10 Years of Liver Surveillance Undertaken in Uveal Melanoma Patients Treated at the Supraregional “Liverpool Ocular Oncology Centre”, UK
Cancers
liver surveillance
frequency
modality
detection of metastases
LUMPO3 model
new output of LUMPO3
title A Retrospective Analysis of 10 Years of Liver Surveillance Undertaken in Uveal Melanoma Patients Treated at the Supraregional “Liverpool Ocular Oncology Centre”, UK
title_full A Retrospective Analysis of 10 Years of Liver Surveillance Undertaken in Uveal Melanoma Patients Treated at the Supraregional “Liverpool Ocular Oncology Centre”, UK
title_fullStr A Retrospective Analysis of 10 Years of Liver Surveillance Undertaken in Uveal Melanoma Patients Treated at the Supraregional “Liverpool Ocular Oncology Centre”, UK
title_full_unstemmed A Retrospective Analysis of 10 Years of Liver Surveillance Undertaken in Uveal Melanoma Patients Treated at the Supraregional “Liverpool Ocular Oncology Centre”, UK
title_short A Retrospective Analysis of 10 Years of Liver Surveillance Undertaken in Uveal Melanoma Patients Treated at the Supraregional “Liverpool Ocular Oncology Centre”, UK
title_sort retrospective analysis of 10 years of liver surveillance undertaken in uveal melanoma patients treated at the supraregional liverpool ocular oncology centre uk
topic liver surveillance
frequency
modality
detection of metastases
LUMPO3 model
new output of LUMPO3
url https://www.mdpi.com/2072-6694/14/9/2187
work_keys_str_mv AT aldacunharola aretrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT helenkalirai aretrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT azzamfgtaktak aretrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT antonioeleuteri aretrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT yaminikrishna aretrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT rumanahussain aretrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT heinrichheimann aretrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT sarahecoupland aretrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT aldacunharola retrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT helenkalirai retrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT azzamfgtaktak retrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT antonioeleuteri retrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT yaminikrishna retrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT rumanahussain retrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT heinrichheimann retrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk
AT sarahecoupland retrospectiveanalysisof10yearsofliversurveillanceundertakeninuvealmelanomapatientstreatedatthesupraregionalliverpoolocularoncologycentreuk